Oppainful neuron-microglia interactions in the trigeminal sensory system

Open Pain Journal

Volumn 3, Issue 1, 2010, Pages 14-28

  Davies, Alexander J ^a   Kim, Yong Ho ^a   Oh, Seog Bae ^a  

^a Seoul National University   (South Korea)

Author keywords

Astrocyte; C fiber; Medullary dorsal horn; Migraine; Nerve injury; Neuropathic pain; P2x receptor; Potassium channels; Subnucleus caudalis

Indexed keywords

CALCIUM ACTIVATED POTASSIUM CHANNEL; CHEMOKINE; CYTOKINE; METABOTROPIC RECEPTOR; POTASSIUM CHANNEL; PURINERGIC P2X RECEPTOR; PURINERGIC RECEPTOR; VOLTAGE GATED POTASSIUM CHANNEL;

ARTICLE; ASTROCYTE; BRAIN SLICE; HUMAN; MICROGLIA; MIGRAINE; NERVE CELL; NERVE INJURY; NEUROANATOMY; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; TRIGEMINAL NERVE; TRIGEMINAL NERVE INJURY; TRIGEMINAL SUBNUCLEUS CAUDALIS; TRIGEMINUS NEURALGIA;

EID: 77953780135     PISSN: None     EISSN: 18763863     Source Type: Journal    
DOI: 10.2174/1876386301003010014     Document Type: Article

References (196)

1. Sessle BJ. Acute and chronic craniofacial pain: brainstem mechanisms of nociceptive transmission and neuroplasticity, and their clinical correlates. Crit Rev Oral Biol Med 2000; 11: 57-91.
2. Elias WJ, Burchiel KJ. Trigeminal neuralgia and other neuropathic pain syndromes of the head and face. Curr Pain Headache Rep 2002; 6: 115-24.
3. Fried K, Lillesaar C, Sime W, Kaukua N, Patarroyo M. Target finding of pain nerve fibers: neural growth mechanisms in the tooth pulp. Physiol Behav 2007; 92: 40-45.
4. Meng ID, Bereiter DA. Differential distribution of Fos-like immu-noreactivity in the spinal trigeminal nucleus after noxious and in-nocuous thermal and chemical stimulation of rat cornea. Neuroscience 1996; 72: 243-54.
5. Bolton S, O'Shaughnessy CT, Goadsby PJ. Properties of neurons in the trigeminal nucleus caudalis responding to noxious dural and facial stimulation. Brain Res 2005; 1046: 122-29.
6. Bereiter DA, Hirata H, Hu JW. Trigeminal subnucleus caudalis: beyond homologies with the spinal dorsal horn. Pain 2000; 88: 221-24.
7. Wallace JM. Update on pharmacotherapy guidelines for treatment of neuropathic pain. Curr Pain Headache Rep 2007; 11: 208-14.
8. Rauck RL, Wallace MS, Burton AW, Kapural L, North JM. Intra-thecal ziconotide for neuropathic pain: a review. Pain Pract 2009; 9: 327-37.
9. Pietrobon D, Striessnig J. Neurobiology of migraine. Nat Rev Neurosci 2003; 4: 386-98.
10. Cruccu G, Gronseth G, Alksne J, et al. AAN-EFNS guidelines on trigeminal neuralgia management. Eur J Neurol 2008; 15: 1013-28.
11. Bussone G, Franzini A, Proietti A, et al. Deep brain stimulation in craniofacial pain: seven years' experience. Neurol Sci 2007; 28 (Suppl 2): S146-49.
12. Sicher H. Oral Anatomy. 3rd ed. St. Louis: C. V. Mosby Co.; 1960.
13. Hirata H, Okamoto K, Tashiro A, Bereiter DA. A novel class of neurons at the trigeminal subnucleus interpolaris/caudalis transition region monitors ocular surface fluid status and modulates tear production. J Neurosci 2004; 24: 4224-32.
14. DaSilva AF, Becerra L, Makris N, et al. Somatotopic activation in the human trigeminal pain pathway. J Neurosci 2002; 22: 8183-92.
15. Wang H, Wei F, Dubner R, Ren K. Selective distribution and function of primary afferent nociceptive inputs from deep muscle tissue to the brainstem trigeminal transition zone. J Comp Neurol 2006; 498: 390-402.
16. Gerard MEW. Afferent impulses of the trigeminal nerve: the intra-medullary course of the painful, thermal and tactile impulses. Arch Neurol Psychiat 1923; 9: 306-38.
17. Kerr FW. The fine structure of the subnucleus caudalis of the tri-geminal nerve. Brain Res 1970; 23: 129-45.
18. Sugimoto T, Fujiyoshi Y, Xiao C, He YF, Ichikawa H. Central projection of calcitonin gene-related peptide (CGRP)- and substance P (SP)-immunoreactive trigeminal primary neurons in the rat. J Comp Neurol 1997; 378: 425-42.
19. Olszewski J. On the anatomical and functional organization of the spinal trigeminal nucleus. J Comp Neurol 1950; 92: 401-13.
20. Rexed B. The cytoarchitectonic organization of the spinal cord in the cat. J Comp Neurol 1952; 96: 414-95.
21. Melzack R, Wall PD. Pain mechanisms: a new theory. Science 1965; 150: 971-79.
22. Willis WD, Coggeshall RE. Sensory mechanisms of the spinal cord. New York; London: Kluwer Academic/Plenum 2004.
23. Ambalavanar R, Morris R. The distribution of binding by isolectin I-B4 from Griffonia simplicifolia in the trigeminal ganglion and brainstem trigeminal nuclei in the rat. Neuroscience 1992; 47: 421-29.
24. Sugimoto T, Fujiyoshi Y, He YF, Xiao C, Ichikawa H. Trigeminal primary projection to the rat brain stem sensory trigeminal nuclear complex and surrounding structures revealed by anterograde transport of cholera toxin B subunit-conjugated and Bandeiraea simplicifolia isolectin B4-onjugated horseradish peroxidase. Neurosci Res 1997; 28: 361-71.
25. Sjöqvist O. Studies on pain conduction in the trigeminal nerve: A contribution to the surgical treatment of facial pain. Acta Psychiat Neurol Scand 1938; (Suppl XVII): 1-139.
26. Pajot J, Pelissier T, Sierralta F, Raboisson P, Dallel R. Differential effects of trigeminal tractotomy on Adelta- and C-fiber-mediated nociceptive responses. Brain Res 2000; 863: 289-92.
27. McMahon SB, Priestley JV. Nociceptor plasticity. In: Hunt S, Koltzenburg M eds, The Neurobiology of Pain. Oxford: Oxford University Press 2005: 35-64.
28. Henry MA, Nousek-Goebl NA, Westrum LE. Light and electron microscopic localization of calcitonin gene-related peptide immu-noreactivity in lamina II of the feline trigeminal pars cauda-lis/medullary dorsal horn: a qualitative study. Synapse 1993; 13: 99-107.
29. Tal M, Devor M. Ectopic discharge in injured nerves: comparison of trigeminal and somatic afferents. Brain Res 1992; 579: 148-51.
30. Benoliel R, Eliav E, Tal M. No sympathetic nerve sprouting in rat trigeminal ganglion following painful and non-painful infraorbital nerve neuropathy. Neurosci Lett 2001; 297: 151-54.
31. Bongenhielm U, Boissonade FM, Westermark A, Robinson PP, Fried K. Sympathetic nerve sprouting fails to occur in the trigeminal ganglion after peripheral nerve injury in the rat. Pain 1999; 82: 283-88.
32. Juhl GI, Jensen TS, Norholt SE, Svensson P. Central sensitization phenomena after third molar surgery: a quantitative sensory testing study. Eur J Pain 2008; 12: 116-27.
33. Piao ZG, Cho IH, Park CK, et al. Activation of glia and microglial p38 MAPK in medullary dorsal horn contributes to tactile hyper-sensitivity following trigeminal sensory nerve injury. Pain 2006; 121: 219-31.
34. Saito K, Hitomi S, Suzuki I, et al. Modulation of trigeminal spinal subnucleus caudalis neuronal activity following regeneration of transected inferior alveolar nerve in rats. J Neurophysiol 2008; 99: 2251-63.
35. Xu M, Aita M, Chavkin C. Partial infraorbital nerve ligation as a model of trigeminal nerve Injury in the mouse: behavioral, neural, and glial reactions. J Pain 2008; 9(11): 1036-48.
36. Eriksson NP, Persson JK, Svensson M, et al. A quantitative analysis of the microglial cell reaction in central primary sensory projection territories following peripheral nerve injury in the adult rat. Exp Brain Res 1993; 96: 19-27.
37. Melzer P, Zhang MZ, McKanna JA. Infraorbital nerve transection and whisker follicle removal in adult rats affect microglia and astrocytes in the trigeminal brainstem. A study with lipocortin1- and S100beta-immunohistochemistry. Neuroscience 1997; 80: 459-72.
38. Jacquin MF, Semba K, Egger MD, Rhoades RW. Organization of HRP-labeled trigeminal mandibular primary afferent neurons in the rat. J Comp Neurol 1983; 215: 397-20.
39. Marfurt CF. The central projections of trigeminal primary afferent neurons in the cat as determined by the tranganglionic transport of horseradish peroxidase. J Comp Neurol 1981; 203: 785-98.
40. Wei F, Guo W, Zou S, Ren K, Dubner R. Supraspinal glial-neuronal interactions contribute to descending pain facilitation. J Neurosci 2008; 28: 10482-95.
41. Lim EJ, Jeon HJ, Yang GY, et al. Intracisternal administration of mitogen-activated protein kinase inhibitors reduced mechanical allodynia following chronic constriction injury of infraorbital nerve in rats. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 1322-29.
42. Goadsby PJ. The vascular theory of migraine-a great story wrecked by the facts. Brain 2009; 132: 6-7.
43. Burstein R, Yamamura H, Malick A, Strassman AM. Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons. J Neurophysiol 1998; 79: 964-82.
44. Jakubowski M, Levy D, Goor-Aryeh I, et al. Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors. Headache 2005; 45: 850-61.
45. Tomimoto H, Shibata M, Ihara M, et al. A comparative study on the expression of cyclooxygenase and 5-lipoxygenase during cerebral ischemia in humans. Acta Neuropathol 2002; 104: 601-07.
46. Tanaka S, Nakamura T, Sumitani K, et al. Stage- and region-specific cyclooxygenase expression and effects of a selective COX-1 inhibitor in the mouse amygdala kindling model. Neurosci Res 2009; 65: 79-87.
47. Schwab JM, Brechtel K, Nguyen TD, Schluesener HJ. Persistent accumulation of cyclooxygenase-1 (COX-1) expressing microglia/macrophages and upregulation by endothelium following spinal cord injury. J Neuroimmunol 2000; 111: 122-30.
48. Bartley J. Could glial activation be a factor in migraine? Med Hypotheses 2009; 72: 255-57.
49. Hutchinson MR, Northcutt AL, Chao LW, et al. Minocycline suppresses morphine-induced respiratory depression, suppresses morphine-induced reward, and enhances systemic morphine-induced analgesia. Brain Behav Immun 2008; 22(8):1248-56.
50. Raghavendra V, Rutkowski MD, DeLeo JA. The role of spinal neuroimmune activation in morphine tolerance/hyperalgesia in neuropathic and sham-operated rats. J Neurosci 2002; 22: 9980-89.
51. Horvath RJ, DeLeo JA. Morphine enhances microglial migration through modulation of P2X4 receptor signaling. J Neurosci 2009; 29: 998-1005.
52. Nurmikko TJ. Pathophysiology of MS-related trigeminal neuralgia. Pain 2009; 143: 165-66.
53. Cruccu G, Biasiotta A, Di Rezze S, et al. Trigeminal neuralgia and pain related to multiple sclerosis. Pain 2009; 143: 186-91.
54. Napoli I, Neumann H. Protective effects of microglia in multiple sclerosis. Exp Neurol 2009.; dói: 10.1016/j.expneurol.2009. 04.024
55. Zhang Z, Zhang ZY, Fauser U, Schluesener HJ. Mechanical allodynia and spinal up-regulation of P2X4 receptor in experimental autoimmune neuritis rats. Neuroscience 2008; 152: 495-501.
56. Yeo JF, Liu HP, Leong SK. Sustained microglial immunoreactivity in the caudal spinal trigeminal nucleus after formalin injection. J Dent Res 2001; 80: 1524-29.
57. Xie YF, Zhang S, Chiang CY, et al. Involvement of glia in central sensitization in trigeminal subnucleus caudalis (medullary dorsal horn). Brain Behav Immunol 2007; 21: 634-41.
58. Xie YF. Glial involvement in trigeminal central sensitization. Acta Pharmacol Sin 2008; 29: 641-45.
59. Dong H, Tian YK, Xiang HB, Tian XB, Jin XG. [The cellular location and significance of p38alpha/beta isoforms in the lumbar spinal cord of the bone cancer pain rats]. Zhonghua Yi Xue Za Zhi 2007; 87: 53-57.
60. Korb A, Tohidast-Akrad M, Cetin E, et al. Differential tissue expression and activation of p38 MAPK alpha, beta, gamma, and delta isoforms in rheumatoid arthritis. Arthritis Rheum 2006; 54: 2745-56.
61. Guo W, Wang H, Watanabe M, et al. Glial-cytokine-neuronal interactions underlying the mechanisms of persistent pain. J Neurosci 2007; 27: 6006-18.
62. Dubner R, Ren K. Brainstem mechanisms of persistent pain following injury. J Orofac Pain 2004; 18: 299-305.
63. Han SM, Ahn DK, Youn DH. Pharmacological analysis of excitatory and inhibitory synaptic transmission in horizontal brainstem slices preserving three subnuclei of spinal trigeminal nucleus. J Neurosci Methods 2008; 167: 221-28.
64. Ren K, Dubner R. Neuron-glia crosstalk gets serious: role in pain hypersensitivity. Curr Opin Anaesthesiol 2008; 21: 570-79.
65. Yihong Z, Tamada Y, Akai K, Suwa F. Morphological interrelationship between astrocytes and nerve endings in the rat spinal trigeminal nucleus caudalis. Okajimas Folia Anat Jpn 2006; 83: 91-96.
66. Verkhratsky A, Kirchhoff F. Glutamate-mediated neuronal-glial transmission. J Anat 2007; 210: 651-60.
67. Chiang CY, Wang J, Xie YF, et al. Astroglial glutamate-glutamine shuttle is involved in central sensitization of nociceptive neurons in rat medullary dorsal horn. J Neurosci 2007; 27: 9068-76.
68. Bordey A, Spencer DD. Chemokine modulation of high-conductance Ca(2+)-sensitive K(+) currents in microglia from human hippocampi. Euro J Neurosci 2003; 18: 2893-98.
69. Dubner R. Plasticity in central nociceptive pathways. In: Merskey H, Loeser JD, Dubner R, Eds. The paths of pain, 1975-2005. Seattle: IASP Press 2005; 101-15.
70. Bereiter DA, Hathaway CB, Benetti AP. Caudal portions of the spinal trigeminal complex are necessary for autonomic responses and display Fos-like immunoreactivity after corneal stimulation in the cat. Brain Res 1994; 657: 73-82.
71. Dallel R, Duale C, Molat JL. Morphine administered in the substantia gelatinosa of the spinal trigeminal nucleus caudalis inhibits nociceptive activities in the spinal trigeminal nucleus oralis. J Neurosci 1998; 18: 3529-36.
72. Hu B, Chiang CY, Hu JW, Dostrovsky JO, Sessle BJ. P2X receptors in trigeminal subnucleus caudalis modulate central sensitization in trigeminal subnucleus oralis. J Neurophysiol 2002; 88: 1614-24.
73. Park SJ, Zhang S, Chiang CY, et al. Central sensitization induced in thalamic nociceptive neurons by tooth pulp stimulation is dependent on the functional integrity of trigeminal brainstem subnucleus caudalis but not subnucleus oralis. Brain Res 2006; 1112: 134-45.
74. Seo K, Fujiwara N, Takeuchi K, Maeda T, Someya G. Postnatal development of excitation propagation in the trigeminal subnucleus caudalis evoked by afferent stimulation in mice. Neurosci Res 2005; 52: 201-10.
75. Chiang CY, Zhang S, Xie YF, et al. Endogenous ATP involvement in mustard-oil-induced central sensitization in trigeminal subnucleus caudalis (medullary dorsal horn). J Neurophysiol 2005; 94: 1751-60.
76. Hathway GJ, Vega-Avelaira D, Moss A, Ingram R, Fitzgerald M. Brief, low frequency stimulation of rat peripheral C-fibres evokes prolonged microglial-induced central sensitization in adults but not in neonates. Pain 2009; 144: 110-18.
77. Wen YR, Suter MR, Kawasaki Y, et al. Nerve conduction blockade in the sciatic nerve prevents but does not reverse the activation of p38 mitogen-activated protein kinase in spinal microglia in the rat spared nerve injury model. Anesthesiology 2007; 107: 312-21.
78. Coull JA, Beggs S, Boudreau D, et al. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 2005; 438: 1017-21.
79. Kim D, Kim MA, Cho IH, et al. A critical role of toll-like receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity. J Biol Chem 2007; 282: 14975-983.
80. Karp HL, Tillotson ML, Soria J, Reich C, Wood JG. Microglial tyrosine phosphorylation systems in normal and degenerating brain. Glia 1994; 11: 284-90.
81. Griffith R, Soria J, Wood JG. Regulation of microglial tyrosine phosphorylation in response to neuronal injury. Exp Neurol 2000; 161: 297-305.
82. Mori I, Goshima F, Koshizuka T, et al. Iba1-expressing microglia respond to herpes simplex virus infection in the mouse trigeminal ganglion. Brain Res Mol Brain Res 2003; 120: 52-56.
83. Westrum LE, Black RG. Changes in the synapses of the spinal trigeminal nucleus after ipsilateral rhizotomy. Brain Res 1968; 11: 706-9.
84. Arvidsson J. An ultrastructural study of transganglionic degeneration in the main sensory trigeminal nucleus of the rat. J Neurocytol 1979; 8: 31-45.
85. Beggs S, Salter MW. Stereological and somatotopic analysis of the spinal microglial response to peripheral nerve injury. Brain Behav Immun 2007; 21: 624-33.
86. Waite PM. Rearrangement of neuronal responses in the trigeminal system of the rat following peripheral nerve section. J Physiol 1984; 352: 425-45.
87. Woolf CJ, Shortland P, Coggeshall RE. Peripheral nerve injury triggers central sprouting of myelinated afferents. Nature 1992; 355: 75-78.
88. Mannion RJ, Doubell TP, Coggeshall RE, Woolf CJ. Collateral sprouting of uninjured primary afferent A-fibers into the superficial dorsal horn of the adult rat spinal cord after topical capsaicin treatment to the sciatic nerve. J Neurosci 1996; 16: 5189-95.
89. De Riu PL, Russo A, Pellitteri R, et al. Primary afferent plasticity following deafferentation of the trigeminal brainstem nuclei in the adult rat. Exp Neurol 2008; 213: 101-7.
90. Noda M, Nakanishi H, Nabekura J, Akaike N. AMPA-kainate subtypes of glutamate receptor in rat cerebral microglia. J Neurosci 2000; 20: 251-58.
91. Matsuka Y, Ono T, Iwase H, et al. Altered ATP release and metabolism in dorsal root ganglia of neuropathic rats. Mol Pain 2008; 4: 66.
92. Masuda J, Tsuda M, Tozaki-Saitoh H, Inoue K. Intrathecal delivery of PDGF produces tactile allodynia through its receptors in spinal microglia. Mol Pain 2009; 5: 23.
93. Marriott I. The role of tachykinins in central nervous system in-flammatory responses. Front Biosci 2004; 9: 2153-65.
94. Jung S, Aliberti J, Graemmel P, et al. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol 2000; 20: 4106-14.
95. Maciejewski-Lenoir D, Chen S, Feng L, Maki R, Bacon KB. Characterization of fractalkine in rat brain cells: migratory and activation signals for CX3CR-1-expressing microglia. J Immunol 1999; 163: 1628-35.
96. Harrison JK, Jiang Y, Chen S, et al. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc Natl Acad Sci USA 1998; 95: 10896-901.
97. Milligan E, Zapata V, Schoeniger D, et al. An initial investigation of spinal mechanisms underlying pain enhancement induced by fractalkine, a neuronally released chemokine. Eur J Neurosci 2005; 22: 2775-82.
98. Clark AK, Yip PK, Malcangio M. The liberation of fractalkine in the dorsal horn requires microglial cathepsin S. J Neurosci 2009; 29: 6945-54.
99. Lyons A, Lynch AM, Downer EJ, et al. Fractalkine-induced activation of the phosphatidylinositol-3 kinase pathway attentuates microglial activation in vivo and in vitro. J Neurochem 2009; 110: 1547-56.
100. Lyons A, Downer EJ, Crotty S, et al. CD200 ligand receptor interaction modulates microglial activation in vivo and in vitro: a role for IL-4. J Neurosci 2007; 27: 8309-13.
101. Lynch MA. The multifaceted profile of activated microglia. Mol Neurobiol 2009; 40: 139-56.
102. Fried K, Bongenhielm U, Boissonade FM, Robinson PP. Nerve injury-induced pain in the trigeminal system. Neuroscientist 2001; 7: 155-65.
103. Goadsby PJ. Calcitonin gene-related peptide antagonists as treatments of migraine and other primary headaches. Drugs 2005; 65: 2557-67.
104. Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 1990; 28: 183-87.
105. Tepper SJ, Cleves C. Telcagepant, a calcitonin gene-related peptideantagonist for the treatment of migraine. Curr Opin Investig Drugs 2009; 10: 711-20.
106. Capuano A, De Corato A, Lisi L, et al. Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology. Mol Pain 2009; 5: 43.
107. Li J, Vause CV, Durham PL. Calcitonin gene-related peptide stimulation of nitric oxide synthesis and release from trigeminal ganglion glial cells. Brain Res 2008; 1196: 22-32.
108. Takeda M, Tanimoto T, Kadoi J, et al. Enhanced excitability of nociceptive trigeminal ganglion neurons by satellite glial cytokine following peripheral inflammation. Pain 2007; 129: 155-66.
109. Ceruti S, Fumagalli M, Villa G, Verderio C, Abbracchio MP. Purinoceptor-mediated calcium signaling in primary neuron-glia trigeminal cultures. Cell Calcium 2008; 43: 576-90.
110. Ruan HZ, Moules E, Burnstock G. Changes in P2X3 purinoceptors in sensory ganglia of the mouse during embryonic and postnatal development. Histochem Cell Biol 2004; 122: 539-51.
111. Vulchanova L, Riedl MS, Shuster SJ, et al. P2X3 is expressed by DRG neurons that terminate in inner lamina II. Eur J Neurosci 1998; 10: 3470-78.
112. Staikopoulos V, Sessle BJ, Furness JB, Jennings EA. Localization of P2X2 and P2X3 receptors in rat trigeminal ganglion neurons. Neuroscience 2007; 144: 208-16.
113. Ambalavanar R, Moritani M, Dessem D. Trigeminal P2X3 receptor expression differs from dorsal root ganglion and is modulated by deep tissue inflammation. Pain 2005; 117: 280-91.
114. Fabbretti E, D'Arco M, Fabbro A, et al. Delayed upregulation of ATP P2X3 receptors of trigeminal sensory neurons by calcitonin gene-related peptide. J Neurosci 2006; 26: 6163-71.
115. Eriksson J, Bongenhielm U, Kidd E, Matthews B, Fried K. Distribution of P2X3 receptors in the rat trigeminal ganglion after inferior alveolar nerve injury. Neurosci Lett 1998; 254: 37-40.
116. Shinoda M, Kawashima K, Ozaki N, et al. P2X3 receptor mediates heat hyperalgesia in a rat model of trigeminal neuropathic pain. J Pain 2007; 8: 588-97.
117. Davies AJ, North RA. Electrophysiological and morphological properties of neurons in the substantia gelatinosa of the mouse trigeminal subnucleus caudalis. Pain 2009; 146: 214-21.
118. Fields RD, Burnstock G. Purinergic signalling in neuron-glia interactions. Nat Rev Neurosci 2006; 7: 423-36.
119. Kato F, Imura T, Shigetomi E. [Purinergic regulatory complex in the brain synapses]. Nihon Shinkei Seishin Yakurigaku Zasshi 2007; 27: 117-26.
120. Latremoliere A, Mauborgne A, Masson J, et al. Differential implication of proinflammatory cytokine interleukin-6 in the development of cephalic versus extracephalic neuropathic pain in rats. J Neurosci 2008; 28: 8489-501.
121. Binshtok AM, Wang H, Zimmermann K, et al. Nociceptors are interleukin-1beta sensors. J Neurosci 2008; 28: 14062-73.
122. Tsuda M, Masuda T, Kitano J, et al. IFN-gamma receptor signaling mediates spinal microglia activation driving neuropathic pain. Proc Natl Acad Sci USA 2009; 106: 8032-37.
123. Ulmann L, Hatcher JP, Hughes JP, et al. Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain. J Neurosci 2008; 28: 11263-68.
124. Svensson M, Eriksson NP, Aldskogius H. Evidence for activation of astrocytes via reactive microglial cells following hypoglossal nerve transection. J Neurosci Res 1993; 35: 373-81.
125. Kawasaki Y, Zhang L, Cheng JK, Ji RR. Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J Neurosci 2008; 28: 5189-94.
126. Tsuda M, Shigemoto-Mogami Y, Koizumi S, et al. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 2003; 424: 778-83.
127. Gao YJ, Zhang L, Samad OA, et al. JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain. J Neurosci 2009; 29: 4096-108.
128. Thomas WE. Brain macrophages: evaluation of microglia and their functions. Brain Res 1992; 17: 61-74.
129. Hickey WF. Basic principles of immunological surveillance of the normal central nervous system. Glia 2001; 36: 118-24.
130. Davalos D, rutzendler J, Yang G, et al. ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 2005; 8: 752-58.
131. Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 1996; 19: 312-18.
132. Bruce-Keller AJ. Microglial-neuronal interactions in synaptic damage and recovery. J Neurosci Res 1999; 58: 191-201.
133. Gonzalez-Scarano F, Baltuch G. Microglia as mediators of inflammatory and degenerative diseases. Annu Rev Neurosci 1999; 22: 219-40.
134. Boucsein C, Kettenmann H, Nolte C. Electrophysiological properties of microglial cells in normal and pathologic rat brain slices. Euro J Neurosci 2000; 12: 2049-58.
135. Hoek RM, Ruuls SR, Murphy CA, et al. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 2000; 290: 1768-71.
136. Ohsawa K, Imai Y, Kanazawa H, Sasaki Y, Kohsaka S. Involvement of Iba1 in membrane ruffling and phagocytosis of macrophages/microglia. J Cell Sci 2000; 113 (Pt 17): 3073-84.
137. Postler E, Rimner A, Beschorner R, Schluesener HJ, Meyermann R. Allograft-inflammatory-factor-1 is upregulated in microglial cells in human cerebral infarctions. J Neuroimmunol 2000; 104: 85-91.
138. Autieri MV, Agrawal N. IRT-1, a novel interferon-gamma-responsive transcript encoding a growth-suppressing basic leucine zipper protein. J Biol Chem 1998; 273: 14731-37.
139. Biber K, Laurie DJ, Berthele A, et al. Expression and signaling of group I metabotropic glutamate receptors in astrocytes and microglia. J Neurochem 1999; 72: 1671-80.
140. Zhang L, McLarnon JG, Goghari V, et al. Cholinergic agonists increase intracellular Ca2+ in cultured human microglia. Neurosci Lett 1998; 255: 33-36.
141. Bader MF, Taupenot L, Ulrich G, Aunis D, Ciesielski-Treska J. Bacterial endotoxin induces [Ca2+]i transients and changes the organization of actin in microglia. Glia 1994; 11: 336-44.
142. Inoue K. Purinergic systems in microglia. Cell Mol Life Sci 2008; 65: 3074-80.
143. Hegg CC, Hu S, Peterson PK, Thayer SA. Beta-chemokines and human immunodeficiency virus type-1 proteins evoke intracellular calcium increases in human microglia. Neuroscience 2000; 98: 191-99.
144. Scholz J, Woolf CJ. The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 2007; 10: 1361-68.
145. D'Aversa TG, Yu KO, Berman JW. Expression of chemokines by human fetal microglia after treatment with the human immunodeficiency virus type 1 protein Tat. J Neurovirol 2004; 10: 86-97.
146. Nakamura Y, Si QS, Kataoka K. Lipopolysaccharide-induced microglial activation in culture: temporal profiles of morphological change and release of cytokines and nitric oxide. Neurosci Res 1999; 35: 95-100.
147. Chauvet N, Palin K, Verrier D, et al. Rat microglial cells secrete predominantly the precursor of interleukin-1beta in response to lipopolysaccharide. Eur J Neurosci 2001; 14: 609-17.
148. Pocock JM, Kettenmann H. Neurotransmitter receptors on microglia. Trends Neurosci 2007; 30: 527-35.
149. Byrnes KR, Stoica B, Riccio A, et al. Activation of metabotropic glutamate receptor 5 improves recovery after spinal cord injury in rodents. Ann Neurol 2009; 66: 63-74.
150. Byrnes KR, Stoica B, Loane DJ, et al. Metabotropic glutamate receptor 5 activation inhibits microglial associated inflammation and neurotoxicity. Glia 2009; 57: 550-60.
151. Loane DJ, Stoica BA, Pajoohesh-Ganji A, Byrnes KR, Faden AI. Activation of metabotropic glutamate receptor 5 modulates microglial reactivity and neurotoxicity by inhibiting NADPH oxidase. J Biol Chem 2009; 284: 15629-39.
152. Taylor DL, Diemel LT, Cuzner ML, Pocock JM. Activation of group II metabotropic glutamate receptors underlies microglial reactivity and neurotoxicity following stimulation with chromogranin A, a peptide up-regulated in Alzheimer's disease. J Neurochem 2002; 82: 1179-91.
153. Taylor DL, Diemel LT, Pocock JM. Activation of microglial group III metabotropic glutamate receptors protects neurons against mi- croglial neurotoxicity. J Neurosci 2003; 23: 2150-60.
154. Ilschner S, Ohlemeyer C, Gimpl G, Kettenmann H. Modulation of potassium currents in cultured murine microglial cells by receptor activation and intracellular pathways. Neuroscience 1995; 66: 983-1000.
155. Brockhaus J, Ilschner S, Banati RB, Kettenmann H. Membrane properties of ameboid microglial cells in the corpus callosum slice from early postnatal mice. J Neurosci 1993; 13: 4412-21.
156. Draheim HJ, Prinz M, Weber JR, et al. Induction of potassium channels in mouse brain microglia: cells acquire responsiveness to pneumococcal cell wall components during late development. Neuroscience 1999; 89: 1379-90.
157. Kettenmann H, Hoppe D, Gottmann K, Banati R, Kreutzberg G. Cultured microglial cells have a distinct pattern of membrane channels different from peritoneal macrophages. J Neurosci Res 1990; 26: 278-87.
158. Eder C. Ion channels in microglia (brain macrophages). Am J Physiol 1998; 275: C327-42.
159. Boucsein C, Zacharias R, Farber K, et al. Purinergic receptors on microglial cells: functional expression in acute brain slices and modulation of microglial activation in vitro. Eur J Neurosci 2003; 17: 2267-76.
160. Kuhn SA, van Landeghem FK, Zacharias R, et al. Microglia express GABA(B) receptors to modulate interleukin release. Mol Cell Neurosci 2004; 25: 312-22.
161. Franciosi S, Ryu JK, Choi HB, et al. Broad-spectrum effects of 4-aminopyridine to modulate amyloid beta1-42-induced cell signaling and functional responses in human microglia. J Neurosci 2006; 26: 11652-64.
162. North RA. Molecular physiology of P2X receptors. Physiol Rev 2002; 82: 1013-67.
163. Chessell IP, Hatcher JP, Bountra C, et al. Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 2005; 114: 386-96.
164. Tsuda M, Kuboyama K, Inoue T, et al. Behavioral phenotypes of mice lacking purinergic P2X4 receptors in acute and chronic pain assays. Mol Pain 2009; 5: 28.
165. Xiang Z, Burnstock G. Expression of P2X receptors on rat microglial cells during early development. Glia 2005; 52: 119-26.
166. Tsuda M, Tozaki-Saitoh H, Masuda T, et al. Lyn tyrosine kinase is required for P2X(4) receptor upregulation and neuropathic pain after peripheral nerve injury. Glia 2008; 56: 50-58.
167. Ferrari D, Chiozzi P, Falzoni S, Hanau S, Di Virgilio F. Purinergic modulation of interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin. J Exp Med 1997; 185: 579-82.
168. Trang T, Beggs S, Wan X, Salter MW. P2X4-receptor-mediated synthesis and release of brain-derived neurotrophic factor in microglia is dependent on calcium and p38-mitogen-activated protein kinase activation. J Neurosci 2009; 29: 3518-28.
169. Cavaliere F, Dinkel K, Reymann K. Microglia response and P2 receptor participation in oxygen/glucose deprivation-induced cortical damage. Neuroscience 2005; 136: 615-23.
170. Gong QJ, Li YY, Xin WJ, et al. ATP induces long-term potentiation of C-fiber-evoked field potentials in spinal dorsal horn: the roles of P2X4 receptors and p38 MAPK in microglia. Glia 2009; 57: 583-91.
171. Sim JA, Park CK, Oh SB, Evans RJ, North RA. P2X1 and P2X4 receptor currents in mouse macrophages. Br J Pharmacol 2007; 152: 1283-90.
172. Schilling T, Eder C. Ion channel expression in resting and activated microglia of hippocampal slices from juvenile mice. Brain Res 2007; 1186: 21-28.
173. Schilling T, Nitsch R, Heinemann U, Haas D, Eder C. Astrocyte-released cytokines induce ramification and outward K+ channel expression in microglia via distinct signalling pathways. Eur J Neurosci 2001; 14: 463-73.
174. Caggiano AO, Kraig RP. Prostaglandin E2 and 4-aminopyridine prevent the lipopolysaccharide-induced outwardly rectifying potassium current and interleukin-1beta production in cultured rat microglia. J Neurochem 1998; 70: 2357-68.
175. Chung S, Jung W, Lee MY. Inward and outward rectifying potassium currents set membrane potentials in activated rat microglia. Neurosci Lett 1999; 262: 121-24.
176. Fischer HG, Eder C, Hadding U, Heinemann U. Cytokine-dependent K+ channel profile of microglia at immunologically defined functional states. Neuroscience 1995; 64: 183-91.
177. Franchini L, Levi G, Visentin S. Inwardly rectifying K+ channels influence Ca2+ entry due to nucleotide receptor activation in mi- croglia. Cell Calcium 2004; 35: 449-59.
178. Norenberg W, Gebicke-Haerter PJ, Illes P. Voltage-dependent potassium channels in activated rat microglia. J Physiol 1994; 475: 15-32.
179. Schilling T, Quandt FN, Cherny VV, et al. Upregulation of Kv1.3 K(+) channels in microglia deactivated by TGF-beta. Am J Physiol Cell Physiol 2000; 279: C1123-34.
180. Schlichter LC, Sakellaropoulos G, Ballyk B, Pennefather PS, Phipps DJ. Properties of K+ and Cl- channels and their involvement in proliferation of rat microglial cells. Glia 1996; 17: 225-36.
181. Ilschner S, Nolte C, Kettenmann H. Complement factor C5a and epidermal growth factor trigger the activation of outward potassium currents in cultured murine microglia. Neuroscience 1996; 73: 1109-20.
182. Norenberg W, Gebicke-Haerter PJ, Illes P. Inflammatory stimuliinduce a new K+ outward current in cultured rat microglia. Neurosci Lett 1992; 147: 171-74.
183. Pyo H, Chung S, Jou I, Gwag B, Joe EH. Expression and function of outward K+ channels induced by lipopolysaccharide in microglia. Mol Cells 1997; 7: 610-14.
184. Pannasch U, Farber K, Nolte C, et al. The potassium channels Kv1.5 and Kv1.3 modulate distinct functions of microglia. MolCell Neurosci 2006; 33: 401-11.
185. Norenberg W, Appel K, Bauer J, Gebicke-Haerter PJ, Illes P. Expression of an outwardly rectifying K+ channel in rat microglia cultivated on teflon. Neurosci Lett 1993; 160: 69-72.
186. Kotecha SA, Schlichter LC. A Kv1.5 to Kv1.3 switch in endogenous hippocampal microglia and a role in proliferation. J Neurosci 1999; 19: 10680-93.
187. Nutile-McMenemy N, Elfenbein A, Deleo JA. Minocycline decreases in vitro microglial motility, beta1-integrin, and Kv1.3 channel expression. J Neurochem 2007; 103: 2035-46.
188. Schilling T, Repp H, Richter H, et al. Lysophospholipids induce membrane hyperpolarization in microglia by activation of IKCa1 Ca(2+)-dependent K(+) channels. Neuroscience 2002; 109: 827-35.
189. + channel KCNN4/KCa3.1 contributes to microglia activation and nitric oxide-dependent neurodegeneration. J Neurosci 2007; 27: 234-44.
190. Khanna R, Roy L, Zhu X, Schlichter LC. K+ channels and the microglial respiratory burst. Am J Physiol Cell Physiol 2001; 280: C796-806.
191. Woda A. Pain in the trigeminal system: from orofacial nociception to neural network modeling. J Dent Res 2003; 82: 764-8.
192. Martinez FO, Helming L, Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 2009; 27: 451-83.
193. Kohno T, Moore KA, Baba H, Woolf CJ. Peripheral nerve injury alters excitatory synaptic transmission in lamina II of the rat dorsal horn. J Physiol 2003; 548: 131-8.
194. Lu VB, Biggs JE, Stebbing MJ, et al. BDNF drives the changes in excitatory synaptic transmission in the rat superficial dorsal horn that follow sciatic nerve injury. J Physiol 2009; 587: 1013-32.
195. Sedlacek M, Horak M, Vyklicky L, Jr. Morphology and physiology of lamina I neurons of the caudal part of the trigeminal nucleus. Neuroscience 2007; 147: 325-33.
196. Borsook D, Burstein R, Moulton E, Becerra L. Functional imaging of the trigeminal system: applications to migraine pathophysiology. Headache 2006; 46(Suppl 1): S32-38.